| |
|
|
|
|
Connective Therapeutics, Inc.(CNCT)
|
|
|
|
|
|
|
|
|
| 123Jump Rating: |
|
Underwriters: |
Salomon Smith Barney
|
| |
|
|
Warburg Dillon Read LLC
|
| Status: |
|
|
Punk, Ziegel & Knoell
|
| |
| Address: |
3400 W. Bayshore Rd.,
|
FiledDate: |
|
| |
|
|
|
| |
|
Filed Price Range ($): |
|
| |
|
|
|
| Telephone: |
(415) 843-2800 |
Filed Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Fax: |
|
Shares Offered (Millions): |
2,500,000 |
| |
|
|
|
| Websites: |
|
Shares Outstanding (Millions): |
9,057,393 |
| |
|
|
|
| Management: |
Thomas G. Wiggans, Pres./CEO
|
IPO Date: |
|
| |
Cythia M. Butitta, CFO
|
|
|
| |
Edward P. Amento, M.D., Exec. VP
|
Final Offer Price ($): |
$0.00 |
| |
|
|
|
| Industry: |
|
Final Offer Size (Millions of Shares): |
0.00 |
| |
|
|
|
| Employees: |
42 |
Final Offer Amount ($ Million): |
$0.00 |
| |
|
|
|
| Competitors: |
|
S-1 Forms: |
|
| |
|
|
|
| |
|
|
|
| |
|
|
|
| |
|
|
| |
|
|
| |
|
|
| |
|
|
|
|
|
- Avoid 
- Value Gap 
- Short-Term Growth
- Long-Term Growth 
- Long-Term Value
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income Data |
| Year |
Revenues |
Costs |
Oper Income |
Taxes |
Net Income |
EPS |
| 1993
|
0.00 |
1076 |
-1076 |
0.00 |
-1078 |
-.29 |
| 1994
|
0.00 |
7753 |
-7753 |
0.00 |
-7850 |
-1.84 |
| 1995
|
0.00 |
10384 |
-10384 |
0.00 |
-10372 |
-2.34 |
| 1996
|
428 |
18595 |
-18761 |
0.00 |
-18514 |
-2.72 |
|
|
|
|
|
|
|
| |
|
| |
|
|
